Aspirion Welcomes Brian Lefort as Chief Human Resources Officer
Critical Insights From Hologic Analyst Ratings: What You Need To Know
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Needham analyst Michael Matson maintains $Hologic(HOLX.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 44.3% and a total
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Hologic Analyst Ratings
Hologic: A Buy Rating Amidst Temporary Challenges and Growth Potential
Hologic Authorizes $1.5B Buyback of Common Stock
Express News | Hologic Inc Says on Sept 12, Board Authorized New Stock Repurchase Program, With Five-Year Term, to Repurchase up to $1.5 Bln of Common Stock
Radiofrequency Ablation Device Market Global Forecast Report and Company Analysis 2024-2032 Featuring Boston Scientific, Abbott, AtriCure, Medtronic, Stryker, Smith & Nephew, Conmed and Hologic - ResearchAndMarkets.com
Express News | Hologic Inc : RBC Raises Target Price to $86 From $82
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Investors in Hologic (NASDAQ:HOLX) Have Seen Decent Returns of 60% Over the Past Five Years
Nephron Trims Price Target on Hologic to $92 From $95
Global Breast Biopsy (Core Needle, Vacuum Assisted & Fine Needle Aspiration) Market Insights & Forecasts 2024-2028 Featuring Hologic, Danaher, Becton, Dickinson & Co, Roche, Medtronic, Qiagen - ResearchAndMarkets.com
Hologic(HOLX.US) Officer Sells US$4.24 Million in Common Stock
$Hologic(HOLX.US)$ Officer Oberton Karleen Marie sold 52,679 shares of common stock on Aug 29, 2024 at an average price of $80.557 for a total value of $4.24 million.Source: Announcement What is
Citi Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $95
Citi analyst Patrick B Donnelly maintains $Hologic(HOLX.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate of 50.0% and a total
Citi Remains a Buy on Hologic (HOLX)
Peering Into Hologic's Recent Short Interest
Why Hologic (HOLX) Is a Top Value Stock for the Long-Term